ERBB2 and neoplasm: According to the American Society of Clinical Oncology and the College of American Pathologists (ASCO/CAP) guidelines, a HER2-positive tumor is defined as either IHC(3+) (i.e., overexpressed) or FISH(+) (i.e., amplified) [5].